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ABSTRACT 
Objective: The aim of this study was to identify the multiple ESBL genes in Multidrug-resistant (MDR) Escherichia coli isolated 
in various biological samples in two hospitals of Niamey. 
Methodology: A total of 195 multidrug-resistant Escherichia coli were included in the study. These isolates were tested using 
polymerase chain reaction (PCR) for detection of the presence of bla CTX-M, bla TEM, bla SHV and bla OXA-1 beta-lactamase genes.  
Results:  A total of 27.7% of Escherichia coli isolates were ESBL producing strains. Globaly, the bla TEM gene was the most 
prevalent (70.3%) followed by bla CTX-M (43.1%), bla OXA-1 (31.8%) and bla SHV (4.1%) genes. The four genes type of ESBL were 
founded simultaneously only in stool samples. Furthermore, none bla SHV gene was found in other samples type. 
Conclusion: This study showed the presence of various ESBL genes among clinical MDR Escherichia coli. That is why a rational 
use of antibiotic and appropriate methods of screening ESBL genes in routine laboratories in Niger is needed to control the 
ESBL genes dissemination. 
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Objectifs: Le but de cette étude était d'identifier les multiples gènes de BLSE chez les souches de Escherichia coli multi 
résistantes isolées de différents types d’échantillons biologiques dans deux hôpitaux de Niamey. 
Méthodologie : Un total de 195 Escherichia coli multi résistants a été inclus dans l'étude. Ces isolats ont été testés par la réaction 
de polymérase en chaîne (PCR) pour détecter la présence des gènes bla CTX-M, bla TEM, bla SHV et bla OXA-1. 
Résultats : Au total, 27,7% des isolats de Escherichia coli multi-résistants étaient des souches productrices de BLSE. Globalement 
le gène bla TEM (70,3%) était le plus détecté suivi des autres gènes bla CTX-M (43,1%), bla OXA-1 (31,8%) et bla SHV (4,1%). Notons que 
seul dans les échantillons de selles quatre types de gènes de BLSE ont été trouvés simultanément. Par ailleurs notons qu’aucun 
gène de type bla SHV n'a été trouvé dans les autres types d'échantillons. 
Conclusion : Cette étude avait montré la présence de divers gènes de BLSE chez les souches cliniques de Escherichia coli. C'est 
pourquoi une utilisation rationnelle des antibiotiques et des méthodes appropriées de dépistage des gènes de BLSE dans les 
laboratoires sont nécessaires afin de contrôler la diffusion des gènes de BLSE. 
Mots clés : Escherichia coli multi résistantes, BLSE, gènes bla, PCR, Niamey, Niger 
 
INTRODUCTION 
Resistance to beta-lactam antibiotics is an increasing 
problem and beta-lactamase production in Gram-
negative bacteria, is one of the most common 
mechanisms of drug resistance. Beta-Lactamases, very 
diversified due to their continuous mutation, belong 
to the Ambler classes A (1) and are usually plasmid-
encoded that also harbor resistant genes to other 
antimicrobial classes with resulting multidrug-
resistant isolates (2, 3). These multidrug resistant 
(MDR) Gram negative bacilli belonging to the 
Enterobacteriaceae family are increasingly responsible 
for hospital infections (bacteremia urinary tract and 
intra-abdominal infection) in many countries (4, 5). 
The MDR extended-spectrum beta-lactamase (ESBL) 
producing Enterobacteriaceae have become a concern in 
medical bacteriology regarding antimicrobial 
treatment and infection control in hospitals (6). 
Indeed, these enzymes (ESBL) have the capacity to 
hydrolyze extended-spectrum cephalosporins and 
monobactam antibiotics, but are inhibited by 
clavulanic acid (7, 8). The emergence of ESBL-
producing isolates has important clinical and 
therapeutic implications. High prevalence of ESBL-
producing Enterobacteriaceae has been reported in the 
literature for clinical samples from a variety of 
infection sites (9). In the past decade, there has been a 
significant increase in the prevalence of resistance to 
extended spectrum cephalosporin in Escherichia coli 
(10). From the clinical and epidemiological side, the 
ESBL-producing Escherichia coli represent a significant 
therapeutic challenge as they are resistant to all beta-
lactam antibiotics currently available and other 
antibiotic families alternative (fluoroquinolones, 
cotrimoxazole, aminosides or tetracyclines), to except 
cephamycins (cefoxitin and cefotetan) and 
carbapenems (imipenem and ertapenem) (11, 12). 
Different types of ESBLs have been found in different  
 
countries. There are currently three main ESBL (TEM, 
SHV and CTX-M) types, which are the most 
widespread and clinically relevant (13). The TEM and 
SHV types were first reported from Klebsiella 
pneumoniae in Western Europe. In the late 1990s, the 
prevalence of TEM and SHV had decreased, while 
that of CTX-M, especially associated to species 
Escherichia coli increased (10). The CTX-M type beta-
lactamases represent a rapidly emerging group 
worldwide, which have been found in 
Enterobacteriaceae, particularly in Escherichia coli, 
Klebsiella pneumoniae, Proteus mirabilis and Salmonella 
typhimurium (14). Genotypic tests have the potential 
to accurately identify different genes encoding the 
ESBLs (15). Several reports have described the 
prevalence of ESBLs genes in the Middle East North 
Africa region and most of the Gulf Cooperation 
Countries (16). So the detection of specific genes by 
PCR and sequencing are commonly used for final 
confirmation of ESBL producers. The association of 
ESBLs and the presence of TEM, SHV, OXA and CTX-
M-type enzymes have been investigated in many 
studies (17). However, there are insufficient scientific 
data on the ESBLs gene characterization available 
from Niger. 
To our knowledge, no data are so far available on 
ESBL-producing Escherichia coli clinical isolates in 
Niger. The aim of this study was to screen the 
presence of bla TEM, bla SHV, bla OXA-1 and bla CTX-M 
genes among clinical MDR Escherichia coli isolated 
from various biological samples in Niamey. 
 
MATERIALS AND METHODS 
Samples collection 
The present prospective study was conducted from 
March 2014 to June 2016 in the medical biology 
laboratory of “hôpital national de Niamey” and 
“hôpital national Lamordé” in Niamey, Niger. The 
isolates were obtained from various samples. 
Multidrug resistant Escherichia coli isolates, were 
isolated from stool (n=49), urinary tract infection 
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(n=134), pus (n=7), blood (n=4), and vaginal swabs 
(n=1) samples. 
Bacterial identification and antibiotic susceptibility 
testing 
Isolation, identification, antimicrobial susceptibility 
testing of isolates and phenotypic characterization of 
ESBL were described in our previous study (18). All 
isolates included in this study were multidrug 
resistant. 
 
Preparation of DNA 
Total DNA was extracted as previously described by 
Steward (19) using boiling process. Samples were 
cultured onto Bromo-Cresol Pourpre (BCP) agar and 
incubated at 37°C for 24 hours. For DNA extraction, 
two loopful of each strain were homogenized into 250 
µl of sterile water. The mixture was boiled for 10 min 
and centrifuged for 10 min. After 5 min at room 
temperature, the supernatant was collected and used 
for the PCR reactions. 
 
Detection of bla TEM, bla SHV, bla OXA-1 and bla CTX-
M genes. 
The beta-lactamase genes bla TEM, bla SHV, bla OXA-1, and 
bla CTX-M were detected by PCR using specific primers 
(Table 1). PCR mixtures were prepared by using 2.5 µl 
of template DNA, 4.0 µl of Master Mix PCR (Solis 
BioDyne, Estonia), 0.5 µl of Forward primer, 0.5 µl of 
Reverse primer in a final volume of 20 µl. 
Amplification conditions were 94°C for 5 min 
following 35 cycles of 94°C for 30 Sec, 55°C for 60 Sec, 
and 72°C for 60 Sec with a final extension at 72°C for 
10 min. PCR amplified fragments were separated by 
agarose gel (1% w/v) electrophoresis in 1 X TAE 
buffer and visualized under UV light.
 
TABLE 1: BETA-LACTAMASE GENES PRIMERS 
 
Genes            Primers                        Sequences (5’-3’)                      Amplicon size (bp) 
bla TEM         TEM-F   ATAAAATTCTTGAAGACGAAA               1080 
         TEM-R   GACAGTTACCAATGCTTAATCA 
 bla SHV             SHV-F             TTATCTCCCTGTTAGCCACC                  650 
          SHV-R    GATTTGCTGATTTCGCTCGG 
bla OXA-1          OXA-1-F   ATGAAAAACACAATACATATC  890 
          OXA-1-R   AATTTAGTGTGTTTAGAATGG 
bla CTX-M         CTX-M-F   GTTACAATGTGTGAGAAGCAG  593 
         CTX-M-R    CCGTTTCCGCTATTACAAAC 
 
Ethical considerations 
All biological specimens were collected as part of the 
routine clinical management of patients. The study 
was approved by the medical establishment 
committee of hôpital national de Niamey” and 
“hôpital national Lamordé” in Niamey and 
permission to conduct the study was obtained from 
the hospital authorities of Niger. 
 
Statistical analysis                              
Data analysis was carried out using Microsoft Excel 
2013 and Med Cal version 11.0.1.0. P ˂ 0.05 was 
considered to be statistically significant. 
 
RESULTS  
A total of 195 MDR Escherichia coli were included in 
this study. Among these isolates, 27.7% (54/195) were 
positive for the phenotypic character of extended 
spectrum beta-lactamases. Molecular analysis had 
shown the presence of various beta-lactamase genes. 
The genes identified by PCR method using specific 
primers i.e TEM, SHV CTX-M and OXA-1 on agarose 
gel were shown in Figures 1 and 2. 
 
 
                                                                                                     




FIGURE 2: PCR AMPLIFICATION OF E. COLI bla CTX-M GENES 
Forty nine (49) MDR Escherichia coli isolates from stool 
samples were tested for ESBL resistant genes. Overall, 
bla TEM gene was the most prevalent (93.9%) followed 
by bla OXA-1 (71.4%), bla CTX-M (65.3%) and bla SHV 
(16.3%) (P ˂ 0.0001) (Table 2). All the fourteen (14) 
ESBL isolates  positive by phenotypic method, were 
positive for the bla TEM gene (100%), 85.7% for the bla 
CTX-M gene, 85.7% for the bla OXA-1 gene and 21.4% for 
bla SHV gene (P < 0. 0001) as indicated in Table 3. 
Globally, bla SHV gene was only detected in stool 
samples.  
 











About the 134 MDR Escherichia coli isolated from 
urine samples, bla TEM gene was the most prevalent 
(61.2%), followed by bla CTX-M (33.6%) and bla OXA-1 
(14.9%) respectively (Table 2). Out of the thirty-seven 
(37) ESBL isolates positive by phenotypic method, 27 
(73.0%) were positive for bla TEM gene, 13 (35.1%) for 
bla CTX-M gene, and 3 (8.1%) for bla OXA-1 gene (P ˂ 
0.0001) (Table 3). None of the isolates was positive for 
bla SHV genes. 
The study of seven (7) MDR Escherichia coli isolated 
from pus samples, showed the presence of bla CTX-M 
gene, bla OXA-1 gene and bla TEM gene with a prevalence 
of 71.4%, 71.4% and 57.1% respectively. The bla SHV 
gene was not found in any of the isolates (Table 2). 
There was no significant difference between the 
expressing of these genes in pus samples (P = 0.3735). 
Only the bla CTX-M gene (50%) and bla OXA-1 gene (50%) 
were found in Escherichia coli isolates positive for 
ESBL by phenotypic method (Table 3).  
In the four (4) MDR Escherichia coli isolated from 
blood culture samples, bla TEM, bla OXA-1 and bla CTX-M 
genes were found in 100%, 50%, and 50%  
respectively (Table 2). However, bla TEM (100%), bla 
OXA-1 (100%) and bla CTX-M (100%) were found in 
Escherichia coli isolates producing ESBL by phenotypic 
method (Table 3). 
Concerning vaginal swabs, only bla TEM gene was 
found in Escherichia coli isolates as indicated in Table 2 





 Stools          Urine    Pus      Blood         Vaginal swabs 
  N=49           N=134             N=7        N=4                  N=1 
bla TEM n (%)             46 (93.9)         82 (61.2)           4 (57.1)       4 (100)            1 (100) 
bla SHV n (%)             8 (16.3)            0 (0)                 0 (0)             0 (0)               0 (0) 
bla OXA-1 n (%)           35 (71.4)         20 (14.9)           5 (71.4)       2 (50)         0 (0) 
bla CTX-M n (%)           32 (65.3)         45 (33.6)           5 (71.4)       2 (50)        0 (0) 
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          Stool                                   Urine                             Pus                            Blood                  Vaginal swabs 
ESBL +       ESBL –         ESBL +        ESBL-          ESBL+       ESBL -      ESBL+      ESBL -         ESBL+       ESBL -       
 N=14          N=35             N=37           N=97           N=2            N=5            N=1           N=3             N=0            N=1 
bla TEM n (%)              14 (100)      32 (91.4)        27 (73.0)      55 (56.7)         0 (0)            4 (80)         1 (100)      3 (100)          0 (0)           1 (100) 
bla SHV n (%)                3 (21.4)       5 (14.3)           0 (0)             0 (0)              0 (0)            0 (0)            0 (0)          0 (0)              0 (0)           0 (0) 
bla OXA-1 n (%)            12 (85.7)     23 (65.7)         3 (8.1)        17 (17.5)         1 (50)           4 (80)         1 (100)      1 (33.3)         0 (0)           0 (0) 
bla CTX-M n (%)            12 (85.7)     20 (57.1)        13 (35.1)     32 (33.0)         1 (50)           4 (80)         1 (100)      1 (33.3)         0 (0)           0 (0) 
 
 
In this study, there was co-existence of ESBL genes in 
some Escherichia coli isolates. The co-existence of bla 
TEM and bla CTX-M genes was found in stool, blood, pus 
and urine samples in 63.3%, 50%, 42.9%, 22.4% (P = 0. 
0002) respectively, while bla CTX-M gene and bla OXA-1 
gene were detected in 57.1%, 50.0%, 71.4%, and 4.5%  
respectively. The co-existence of three ESBL genes 
belonging to group bla CTX-M + bla TEM + bla OXA-1 genes 
was observed in 57.1%, 50%, 28.6% and 3% 
respectively from stool, blood, pus and urine samples 
(P < 0. 0001). However, other multiple co-detection of 
ESBL genes belonging to different groups: bla CTX-M + 
bla SHV (14.3%), bla CTX-M + bla TEM + bla SHV (12.2%), bla 
CTX-M + bla SHV + bla OXA-1 (14.3%) were observed in 
stool samples. A combination of four genes (12.2%), 
bla CTX-M + bla TEM + bla SHV + bla OXA-1 genes was found 
only in Escherichia coli isolated from stool samples 
(Table 4). 
 





Over the last decades, many studies have 
demonstrated the presence of ESBL resistance genes 
in bacteria isolated from patients during various 
infections (20 -22). This study reported the results of 
molecular characterization of ESBL resistance genes 
in MDR Escherichia coli strains isolated in two 
hospitals of Niamey, Niger. 
The study of Escherichia coli producing ESBL (14 
isolates) isolated from stool samples, had shown that 
the most frequent ESBL gene was bla TEM followed by 
bla CTX-M , bla OXA-1  and bla SHV genes. However, 
previous studies from Qatar reported a higher 
prevalence of bla CTX-M gene (66.1%), bla SHV (53.2%) 
and bla TEM (40.4%) (9). In another study, the 
predominant ESBL genes, were bla CTX-M, bla TEM and 
bla SHV (23). Other studies in clinical isolates showed 
that E. coli harbored bla SHV  gene (88.9%), bla OXA 
(44.4%) and bla CTX-M genes (44,4), and bla TEM gene 
(22.2%) (24). These results were contradictory to our 
results. The difference would be due to the sampling 
from different hospitals and from different 
geographic locations, whereas in our study, samples 
were collected only from two hospital setting.  
This study revealed that, out of the 37 E coli 
producing ESBL isolated from urine samples, the 
percentage of bla TEM was 73.0% followed by bla CTX-M 
(35.1%) and bla OXA-1 (8.1%). Karimian et al. in Iran, 
reported similar data: bla TEM and bla CTX-M genes were 
observed in 71.2% and 37.3% of E. coli isolates, 
respectively (25). In our study, none of the isolate 
harbored bla SHV gene. A similar finding was reported 
ESBL genes combination 
Clinical sources 
 Stool             Urine         Pus               Blood     Vaginal swabs 
  N=49                N=134                N= 7              N=4                    N=1   
bla CTX-M + bla TEM n (%)       31 (63.3)           30 (22.4)            3 (42.9)     2 (50.0)              0 (0) 
bla CTX-M + bla SHV n (%)         7 (14.3)             0 (0)      0 (0)     0 (0)              0 (0) 
bla CTX-M + bla OXA-1 n (%)       28 (57.1)               6 (4.5)      5 (71.4)     2 (50.0)              0 (0) 
bla CTX-M + bla TEM + bla SHV n (%)         6 (12.2)             0 (0)      0 (0)     0 (0)              0 (0) 
bla CTX-M + bla TEM + bla OXA-1 n (%)       28 (57.1)             4 (3.0)      2 (28.6)     2 (50.0)              0 (0) 
bla CTX-M + bla SHV + bla OXA-1 n (%)         7 (14.3)             0 (0)      0 (0)     0 (0)              0 (0) 
bla CTX-M + bla TEM + bla SHV + bla OXA-1 n (%)       6 (12.2)              0 (0)      0 (0)     0 (0)              0 (0) 
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from Thai studies. (26). But our results contradicted 
those reported in some studies conducted by 
Egyptian and Indian authors, in which bla SHV gene 
was detected among urinary E. coli isolates (27, 28). 
Also, in East Africa, ESBL genes, bla CTX-M, bla TEM, bla 
SHV and bla OXA were found frequently (23). Thus, this 
required a better understanding of the ESBL genes in 
order to give useful data about their epidemiology. 
In this study, only 4 MDR Escherichia coli isolated 
from blood culture were tested for ESBL genes. Thus, 
the co-existence of bla TEM, bla OXA-1 and bla CTX-M was 
only seen in one strain producing EBSL. Our results 
correlated with other results reported in some 
African’s countries which showed a significantly 
lower proportion of ESBL in blood cultures than in 
other specimens (29). The previous finding was 
contradicted with the finding of a Burkina Faso study 
which had shown the highest proportion of ESBL 
genes in blood samples (30). Whereas, none of ESBL-
producing isolates carried bla SHV or bla CTX-M genes as 
reported in Ghana (31). This discrepancy can be 
explained by differences in the antimicrobials use 
between countries.  
The present study reported the multiple co-existence 
of ESBL genes. Thus, 63.3% of isolates from stool 
samples harbored two ESBL genes belonging to 
groups of bla CTX-M + bla TEM, followed by blood 
samples (50%), pus samples (42.9%) and urine 
samples (22.4%). The greatest frequency of beta 
lactamase gene in E. coli samples was related to 
TEM/CTX-M in previous study as reported in Iran 
(32).  The co-existence of bla TEM + bla CTX-M genes and 
bla SHV + bla CTX-M genes in two strains were reported 
in India (33).  
This study revealed that the co-existence of three (3) 
ESBL genes (bla CTX-M + bla TEM + bla OXA-1) was 
observed in 57.1%, 50%, 28.6% and 3% of the 
Escherichia coli isolates respectively in stool, blood, 
pus and urine samples. This result was also found in 
another study conducted in Bangladesh (24). These 
results indicated that ESBL-producing Escherichia coli 
frequently harbored more than one beta-lactamase 
genes. 
Overall, only isolates from stool samples harbored 
simultaneously four (4) ESBL genes (bla CTX-M + bla TEM 
+ bla SHV + bla OXA-1).  According to a previous study in 
Lebanon, 15.9% of Escherichia coli harbored the four 
ESBL genes (34). The genetic diversity of bla genes in 
isolates, suggested that resistance genes can easily 
move from one specie to another with the possibility 
of easy interspecies transfer. 
This study was conducted in two hospitals of 
Niamey; it may reflect the local antibiotic resistance 
patterns and this may be a limitation. 
 
CONCLUSION 
This first study in Niger showed a high incidence of 
ESBL resistance genes among clinical Escherichia coli 
isolates from two laboratories in two hospitals 
(Hôpital National de Niamey and Hôpital National 
Lamordé) of Niamey. Many isolates harboring more 
than one ESBL resistance genes, were also detected. 
Therefore, immediate implementation and 
recommendations for antimicrobial management and 
infection control measures were necessary to prevent 
the spread of these genes across the whole country. 
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